Maryland lawmakers have filed bills to extend the state's psychedelic task force through December 31, 2027, to develop updated recommendations for expanding therapeutic access to novel drugs and potentially creating a regulatory framework for broader legalization, with an initial focus on psilocybin. The task force previously recommended a multi-pathway framework for safe, broad, and equitable access, involving the phased implementation of medical/therapeutic use, supervised adult use, deprioritization measures, and eventual commercial sales.

Maryland Files Bills to Extend Psychedelics Task Force

Jan 27, 2026

Source:

Kyle Jaeger

Marijuana Moment

Maryland is doubling down on the future of plant medicine. Lawmakers recently introduced bills to extend the state’s psychedelic task force through the end of 2027. Originally formed to explore natural substances like psilocybin, this 17-person group is now looking to craft a long-term roadmap for therapeutic access and potential broad legalization. Their vision is a phased rollout, starting with safety boards and decriminalization before eventually moving toward supervised adult use and even commercial sales.

What’s really cool is that the task force isn't waiting on the federal government to make a move; they’re focused on building a "multi-pathway" framework that prioritizes equity and small businesses right here in Maryland. For the everyday toker, this is a massive win. It shows that the same energy that brought us legal cannabis is now opening doors for other natural alternatives. By establishing local regulations instead of sticking to old-school prohibition, Maryland is ensuring the community has safe, legal, and affordable access to these emerging therapies. Stay tuned—this movement is just getting started.